This HTML5 document contains 180 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbthttp://dbpedia.org/resource/Template:
wikipedia-enhttp://en.wikipedia.org/wiki/
n29http://dbpedia.org/resource/Gen._Eng._Biotechnol.
dbrhttp://dbpedia.org/resource/
n8http://www.grid.ac/institutes/grid.419042.
n23https://www.repligen.
n43http://www.streetinsider.com/Management+Changes/Repligen+(RGEN)+Replaces+Board+Member+Alex+Rich+with+Alfred+Goldberg/6796218.
n10http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
schemahttp://schema.org/
n28http://dbpedia.org/resource/Wikt:
n32https://web.archive.org/web/20140315194147/http:/www.fool.com/quote/nasdaq/repligen-corp/rgen/
skoshttp://www.w3.org/2004/02/skos/core#
dcthttp://purl.org/dc/terms/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n19http://localhost:8890/about/id/entity/http/dbpedia.org/class/yago/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n34https://covidontheweb.inria.fr:4443/about/id/entity/http/dbpedia.org/resource/
n30http://dbpedia.org/resource/OPUS_(chromatography)
dbphttp://dbpedia.org/property/
n46http://dbpedia.org/resource/Waltham,
xsdhhttp://www.w3.org/2001/XMLSchema#
n36https://web.archive.org/web/20140315192553/http:/www.forbes.com/profile/alexander-rich/
dbohttp://dbpedia.org/ontology/
n26http://www.fool.com/quote/nasdaq/repligen-corp/rgen/
dbchttp://dbpedia.org/resource/Category:
n20http://dbpedia.org/resource/Incorporation_(business)
yagohttp://dbpedia.org/class/yago/
n14http://rdf.freebase.com/ns/m.
n37http://dbpedia.org/resource/Repligen#
wdhttp://www.wikidata.org/entity/
n11http://purl.org/linguistics/gold/
n41https://global.dbpedia.org/id/
yago-reshttp://yago-knowledge.org/resource/
n33https://web.archive.org/web/20140315195141/http:/www.streetinsider.com/Management+Changes/Repligen+(RGEN)+Replaces+Board+Member+Alex+Rich+with+Alfred+Goldberg/6796218.
n47http://topics.nytimes.com/top/news/business/companies/repligen-corporation/
n27http://dbpedia.org/resource/Friedreich'
n21https://www.forbes.com/profile/alexander-rich/
n15http://dbpedia.org/resource/S&
provhttp://www.w3.org/ns/prov#
foafhttp://xmlns.com/foaf/0.1/
n17http://dbpedia.org/resource/List_of_S&
wdrshttp://www.w3.org/2007/05/powder-s#
n24https://covidontheweb.inria.fr:4443/about/id/entity/http/dbpedia.org/resource/Category:
n25http://corporate.repligen.com/file.aspx%3FIID=4325751&FID=22568361&O=3&OSID=
n44http://dbpedia.org/resource/President_(corporate_title)
n40http://en.wikipedia.org/wiki/Repligen?oldid=1102538891&ns=
n35https://web.archive.org/web/20140315184535/http:/topics.nytimes.com/top/news/business/companies/repligen-corporation/
owlhttp://www.w3.org/2002/07/owl#
Subject Item
dbr:Repligen
rdf:type
dbo:Company yago:Abstraction100002137 owl:Thing yago:Company108058098 n10:SocialPerson wd:Q43229 yago:WikicatManufacturingSupportCompanies yago:WikicatCompaniesBasedInMassachusetts wd:Q4830453 yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity yago:YagoLegalActor dbo:Organisation dbo:Agent yago:SocialGroup107950920 wd:Q24229398 schema:Organization yago:WikicatCompaniesListedOnNASDAQ n10:Agent yago:Organization108008335 yago:Institution108053576 yago:Group100031264
rdfs:label
Repligen
rdfs:comment
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of February 2014, Repligen employed 116 people, about 50% of these based in Sweden.
owl:sameAs
n14:03p31ww wd:Q17078090 n41:fWRZ dbr:Repligen yago-res:Repligen
foaf:name
Repligen Corporation
foaf:homepage
n23:com
dbp:name
Repligen Corporation
foaf:topic
dbr:RG1068 n17:P_400_companies dbr:BioMarin_Pharmaceutical dbr:Cross-flow_filtration dbr:Repligen_Corp dbr:List_of_pharmaceutical_companies dbr:Repligen_Corporation_Award_in_Chemistry_of_Biological_Processes n30: wikipedia-en:Repligen dbr:Spinal_muscular_atrophy n37:this dbr:Russell_1000_Index dbr:Alexander_Rich dbr:Roberta_Farrell
wdrs:describedby
n19:Company108058098 n24:Companies_based_in_Massachusetts n34:Company n34:Spinal_muscular_atrophy
dbp:secCik
730272
dbo:foundedBy
dbr:Alexander_Rich dbr:Paul_Schimmel
dbp:operatingIncome
2.3E7
dbp:tradedAs
NASDAQ:RGEN n15:P_400
dct:subject
dbc:Companies_based_in_Massachusetts dbc:Manufacturing_support_companies dbc:1981_establishments_in_Massachusetts dbc:Companies_listed_on_the_Nasdaq
dbo:wikiPageID
42211934
dbo:wikiPageRevisionID
1102538891
dbo:wikiPageWikiLink
dbr:Marketing_Authorization_Application dbr:Exchange_rate dbr:Spinal_muscular_atrophy dbr:Biological_drug dbr:Bristol-Myers_Squibb dbr:NASDAQ dbr:Contrast_medium dbr:Clinical_trial n15:P_400 dbr:CEO dbr:Orencia dbc:Companies_based_in_Massachusetts dbr:The_Motley_Fool dbr:Board_of_Directors dbr:Cross-flow_filtration n20: dbr:Form_10-K dbr:Pfizer dbr:USFDA dbr:MIT dbc:Manufacturing_support_companies dbr:International_New_York_Times dbr:Lund dbr:Alexander_Rich dbr:BioMarin_Pharmaceutical dbr:Forbes dbr:RG3039 n27:s_ataxia n28:emeritus n29:_News dbr:Delaware_General_Corporation_Law dbr:Swedish_krona dbr:University_of_Michigan dbr:TangenX dbr:Growth_factor dbr:The_Scripps_Research_Institute dbr:Royalties dbr:Chief_executive_officer dbr:Column_chromatography dbr:United_States_dollar dbr:Histone_deacetylase_inhibitor dbr:Project_finance dbr:Novozymes dbr:Exclusive_license dbr:European_Medicines_Agency dbr:Bioproduction dbr:Paul_Schimmel dbr:Intermediary dbr:New_Drug_Application dbr:Company_president dbc:1981_establishments_in_Massachusetts dbc:Companies_listed_on_the_Nasdaq dbr:Public_company dbr:Direct_sales n44: dbr:Protein_A n46:_Massachusetts
dbo:wikiPageExternalLink
n21: n25:9 n26:key-executives n23:com n32:key-executives n33:html n35: n36: n43:html n47:
foaf:isPrimaryTopicOf
wikipedia-en:Repligen
skos:closeMatch
n8:a
dbo:type
dbr:Public_company
dbp:part
Entire article
dbo:assets
1.19E8
prov:wasDerivedFrom
n40:0
n11:hypernym
dbr:Company
dbo:abstract
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of February 2014, Repligen employed 116 people, about 50% of these based in Sweden.
dbo:foundingYear
1981-01-01
dbo:numberOfEmployees
116
dbp:date
August 2022
dbp:founders
Alexander Rich Paul Schimmel
dbp:reason
hasn't been materially touched since 2014
dbp:revenue
6.8E7
dbp:type
dbr:Public_company
dbp:numEmployees
116
dbp:symbol
RGEN
dbp:homepage
n23:com
dbo:equity
1.04E8
dbp:assets
1.19E8
dbp:bloomberg
RGEN:US
dbp:equity
1.04E8
dbp:google
RGEN:NASDAQ
dbp:industry
Pharmaceutical industry
dbp:keyPeople
Tony J. Hunt
dbp:products
Materials used in the manufacture of biological drugs
dbp:reuters
RGEN.O
dbp:yahoo
RGEN
dbp:locationCity
Waltham, Massachusetts
dbp:locationCountry
United States
dbo:wikiPageLength
12559
dbo:revenue
6.8E7
dbo:operatingIncome
2.3E7
dbp:wikiPageUsesTemplate
dbt:Cite_web dbt:Cite_news dbt:Reflist dbt:Start_date_and_age dbt:Finance_links dbt:Sfn dbt:Harvid dbt:Update dbt:Infobox_company dbt:Increase dbt:Authority_control dbt:Short_description dbt:As_of dbt:Citation dbt:Official dbt:Ref dbt:Small